Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Accepts healthy volunteers

gB/MF59 Vaccine in Preventing Cytomegalovirus Infection in Healthy Adolescent Females

ClinicalTrials.gov ID: NCT00133497

Public ClinicalTrials.gov record NCT00133497. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 12:33 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo-Controlled, Phase II Study to Assess the Safety and Efficacy of the Cytomegalovirus gB/MF59 Vaccine in Preventing Systemic Cytomegalovirus Infection in Healthy Adolescent Females

Study identification

NCT ID
NCT00133497
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
Enrollment
409 participants

Conditions and interventions

Interventions

  • MF-59 Biological
  • Placebo Drug
  • CMV gB vaccine Biological

Biological · Drug

Eligibility (public fields only)

Age range
12 Years to 17 Years
Sex
Female
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 31, 2006
Primary completion
May 31, 2013
Completion
May 31, 2013
Last update posted
Jul 5, 2017

2006 – 2013

United States locations

U.S. sites
5
U.S. states
3
U.S. cities
4
Facility City State ZIP Site status
Cincinnati Children's Hospital Medical Center - Infectious Diseases Cincinnati Ohio 45229-3026
Vanderbilt University - Pediatric - Vanderbilt Vaccine Research Center Nashville Tennessee 37232-2573
The University of Texas Medical Branch - Sealy Center for Vaccine Development (SCVD) Galveston Texas 77555-1121
The University of Texas Health Science Center - Pediatrics Houston Texas 77030-1501
Baylor College of Medicine - Molecular Virology and Microbiology Houston Texas 77030-3411

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00133497, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 5, 2017 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00133497 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →